Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: An approach to a personalized medicine
✍ Scribed by Gremese, Elisa ;Carletto, Antonio ;Padovan, Melissa ;Atzeni, Fabiola ;Raffeiner, Bernd ;Giardina, Anna Rita ;Favalli, Ennio Giulio ;Erre, Gian Luca ;Gorla, Roberto ;Galeazzi, Mauro ;Foti, Rosario ;Cantini, Fabrizio ;Salvarani, Carlo ;Olivieri, Ignazio ;Lapadula, Giovanni ;Ferraccioli, Gianfranco ;,
- Book ID
- 118750847
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 2012
- Tongue
- English
- Weight
- 110 KB
- Volume
- 65
- Category
- Article
- ISSN
- 2151-464X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective Patients with rheumatoid arthritis (RA) in whom the response to anti–tumor necrosis factor (anti‐TNF) therapy is inadequate have several therapeutic options, such as switching to an alternative anti‐TNF agent or initiating B cell–depleting therapy with rituximab (RTX). Alt
## Abstract Dynamic contrast‐enhanced MRI (DCE‐MRI) of the hand and wrist was performed in 11 patients with rheumatoid arthritis twice before and once 2 weeks after treatment with anti–tumor necrosis factor (TNF)‐α therapy. A rapid, __T__~1~‐weighted 3D spoiled gradient echo (SPGR) sequence was use